The clinical-stage pharma company, Plus Therapeutics Inc (NASDAQ: PSTV), is known for developing targeted and innovative radiotherapeutics for complex and rare cancers. Last week, the company announced signing an exclusive agreement with ABX Advanced Biochemical Compounds GmbH. According to the agreement, the deal facilitates supplying critical components used in manufacturing […]